Pregnancy: Reproduction studies have been performed in rats at doses up to 500 mg/kg per day and in rabbits at doses up to 300 mg/kg per day and have revealed no evidence of impaired fertility or harm to the foetus due to clopidogrel. There are, however, no adequate and well controlled studies in pregnant women.
Because animal reproduction studies are not always predictive of a human response, this drug should not be used during pregnancy, unless, in the opinion of the physician, there is a clear need.
Lactation: Studies in rats have shown that clopidogrel and/or its metabolites are excreted in the milk. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug. taking into account the importance of the drug to a nursing woman.